Iradimed Corporation (NASDAQ:IRMD) Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its holdings in Iradimed Corporation (NASDAQ:IRMD) by 21.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,518 shares of the medical equipment provider’s stock after selling 2,302 shares during the period. GSA Capital Partners LLP’s holdings in Iradimed were worth $428,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Shaker Investments LLC OH increased its position in shares of Iradimed by 1.7% in the second quarter. Shaker Investments LLC OH now owns 20,605 shares of the medical equipment provider’s stock worth $905,000 after acquiring an additional 347 shares in the last quarter. ClariVest Asset Management LLC increased its position in shares of Iradimed by 2.9% in the second quarter. ClariVest Asset Management LLC now owns 17,666 shares of the medical equipment provider’s stock worth $776,000 after acquiring an additional 494 shares in the last quarter. Cim LLC increased its position in shares of Iradimed by 5.9% in the second quarter. Cim LLC now owns 10,089 shares of the medical equipment provider’s stock worth $464,000 after acquiring an additional 561 shares in the last quarter. Kings Path Partners LLC grew its holdings in Iradimed by 2.3% during the 3rd quarter. Kings Path Partners LLC now owns 24,570 shares of the medical equipment provider’s stock valued at $1,236,000 after purchasing an additional 562 shares in the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new stake in Iradimed during the 2nd quarter valued at $25,000. Institutional investors and hedge funds own 92.34% of the company’s stock.

Iradimed Trading Up 1.6 %

IRMD opened at $52.08 on Thursday. The company has a fifty day simple moving average of $50.81 and a 200 day simple moving average of $46.62. The firm has a market cap of $659.85 million, a price-to-earnings ratio of 35.67 and a beta of 0.79. Iradimed Corporation has a twelve month low of $40.05 and a twelve month high of $57.95.

Iradimed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.60 dividend on an annualized basis and a yield of 1.15%. Iradimed’s dividend payout ratio (DPR) is 41.10%.

Analyst Upgrades and Downgrades

Separately, Roth Mkm lowered their price target on shares of Iradimed from $65.00 to $60.00 and set a “buy” rating for the company in a report on Friday, August 2nd.

Iradimed Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.